Molecular screening and analysis of novel therapeutic inhibitors against c-Jun N-terminal kinase

[1]  Y. Li,et al.  MAPK/JNK signalling: a potential autophagy regulation pathway , 2015, Bioscience reports.

[2]  Thomas Sander,et al.  DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis , 2015, J. Chem. Inf. Model..

[3]  V. Vyas,et al.  Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. , 2013, Journal of molecular graphics & modelling.

[4]  M. Mezei,et al.  Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.

[5]  Katrin Stierand,et al.  PoseView -- molecular interaction patterns at a glance , 2010, J. Cheminformatics.

[6]  Toshimasa Tanaka,et al.  Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2). , 2008, Bioorganic & medicinal chemistry.

[7]  Toshimasa Tanaka,et al.  Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1). , 2008, Bioorganic & medicinal chemistry.

[8]  Zigang Dong,et al.  The functional contrariety of JNK , 2007, Molecular carcinogenesis.

[9]  J. Irwin,et al.  ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. , 2005 .

[10]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[11]  Michael S Lajiness,et al.  Molecular properties that influence oral drug-like behavior. , 2004, Current opinion in drug discovery & development.

[12]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Caron,et al.  Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. , 1998, Structure.

[14]  H. K. Sluss,et al.  Selective interaction of JNK protein kinase isoforms with transcription factors. , 1996, The EMBO journal.

[15]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[16]  J. Avruch,et al.  pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. , 1990, The Journal of biological chemistry.

[17]  Arthur J Olson,et al.  Small-molecule library screening by docking with PyRx. , 2015, Methods in molecular biology.

[18]  John-Michael Sauer,et al.  Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration. , 2011, Bioorganic & medicinal chemistry letters.

[19]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.